Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer.

Tonttila PP, Ahtikoski A, Kuisma M, Pääkkö E, Hirvikoski P, Vaarala MH.

BJU Int. 2019 May 18. doi: 10.1111/bju.14812. [Epub ahead of print]

PMID:
31102571
2.

Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes.

Shah RB, Nguyen JK, Przybycin CG, Reynolds JP, Cox R, Myles J, Klein E, McKenney JK.

Histopathology. 2019 Sep;75(3):346-353. doi: 10.1111/his.13878. Epub 2019 Jul 2.

PMID:
31012493
3.

Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.

Prendeville S, Gertner M, Maganti M, Pintilie M, Perlis N, Toi A, Evans AJ, Finelli A, van der Kwast TH, Ghai S.

J Urol. 2018 Jul;200(1):104-113. doi: 10.1016/j.juro.2018.01.081. Epub 2018 Feb 2.

PMID:
29408568
4.

Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance.

Guo CC, Epstein JI.

Mod Pathol. 2006 Dec;19(12):1528-35. Epub 2006 Sep 15.

5.

GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.

Jeyapala R, Savio AJ, Olkhov-Mitsel E, Kamdar S, Zhao F, Cuizon C, Liu RSC, Zlotta A, Fleshner N, van der Kwast T, Bapat B.

Eur Urol Oncol. 2019 May;2(3):231-238. doi: 10.1016/j.euo.2018.08.003. Epub 2018 Sep 1.

PMID:
31200836
6.

Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.

Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ.

Eur Urol. 2018 Jun;73(6):879-887. doi: 10.1016/j.eururo.2017.11.012. Epub 2017 Nov 28.

PMID:
29195777
7.

[Distribution of intraductal carcinoma of the prostate and associated lesions in the cancer foci on radical prostatectomy specimens].

Sakamoto N, Maki T, Kobayashi S, Kobayashi T, Hamaguchi M, Yoshikawa M, Iguchi A, Momosaki S, Nakayama Y.

Nihon Hinyokika Gakkai Zasshi. 2014 Oct;105(4):163-70; discussion 171. Japanese.

PMID:
25757345
8.

A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.

Chua MLK, Lo W, Pintilie M, Murgic J, Lalonde E, Bhandari V, Mahamud O, Gopalan A, Kweldam CF, van Leenders GJLH, Verhoef EI, Hoogland AM, Livingstone J, Berlin A, Dal Pra A, Meng A, Zhang J, Orain M, Picard V, Hovington H, Bergeron A, Lacombe L, Fradet Y, Têtu B, Reuter VE, Fleshner N, Fraser M, Boutros PC, van der Kwast TH, Bristow RG.

Eur Urol. 2017 Nov;72(5):665-674. doi: 10.1016/j.eururo.2017.04.034. Epub 2017 May 13.

PMID:
28511883
9.

Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy.

Lee H, Kim CK, Park BK, Sung HH, Han DH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.

World J Urol. 2017 Jun;35(6):929-934. doi: 10.1007/s00345-016-1948-6. Epub 2016 Oct 13.

PMID:
27738805
10.

Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.

Lista F, Gimbernat H, Cáceres F, Rodríguez-Barbero JM, Castillo E, Angulo JC.

Actas Urol Esp. 2014 Jun;38(5):290-7. doi: 10.1016/j.acuro.2013.11.003. Epub 2014 Jan 1. English, Spanish.

PMID:
24387827
11.

Comparison of the accuracy of multiparametric magnetic resonance imaging (mpMRI) results with the final pathology findings for radical prostatectomy specimens in the detection of prostate cancer.

Lee CH, Ku JY, Park WY, Lee NK, Ha HK.

Asia Pac J Clin Oncol. 2019 Apr;15(2):e20-e27. doi: 10.1111/ajco.13027. Epub 2018 Jun 19.

PMID:
29920966
12.

Clinical Significance of Multiparametric Magnetic Resonance Imaging as a Preoperative Predictor of Oncologic Outcome in Very Low-Risk Prostate Cancer

Chung DY, Kim MS, Lee JS, Goh HJ, Koh DH, Jang WS, Hong CH, Choi YD.

J Clin Med. 2019 Apr 19;8(4). pii: E542. doi: 10.3390/jcm8040542.

13.

Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.

Radtke JP, Schwab C, Wolf MB, Freitag MT, Alt CD, Kesch C, Popeneciu IV, Huettenbrink C, Gasch C, Klein T, Bonekamp D, Duensing S, Roth W, Schueler S, Stock C, Schlemmer HP, Roethke M, Hohenfellner M, Hadaschik BA.

Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.

PMID:
26810346
14.

A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.

Orczyk C, Rosenkrantz AB, Deng FM, Melamed J, Babb J, Wysock J, Kheterpal E, Huang WC, Stifelman M, Lepor H, Taneja SS.

Urol Oncol. 2016 Jan;34(1):3.e1-8. doi: 10.1016/j.urolonc.2015.07.004. Epub 2015 Aug 31.

PMID:
26338414
15.

Optimising preoperative risk stratification tools for prostate cancer using mpMRI.

Reisæter LAR, Fütterer JJ, Losnegård A, Nygård Y, Monssen J, Gravdal K, Halvorsen OJ, Akslen LA, Biermann M, Haukaas S, Rørvik J, Beisland C.

Eur Radiol. 2018 Mar;28(3):1016-1026. doi: 10.1007/s00330-017-5031-5. Epub 2017 Oct 6.

16.

Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.

Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY.

Hum Pathol. 2014 Aug;45(8):1572-81. doi: 10.1016/j.humpath.2014.03.011. Epub 2014 Apr 12.

PMID:
24842280
17.

Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.

Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26. eCollection 2014.

18.

Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.

Chung DY, Koh DH, Goh HJ, Kim MS, Lee JS, Jang WS, Choi YD.

BMC Cancer. 2018 Nov 1;18(1):1057. doi: 10.1186/s12885-018-4955-8.

19.

Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.

Hickman RA, Yu H, Li J, Kong M, Shah RB, Zhou M, Melamed J, Deng FM.

Am J Surg Pathol. 2017 Apr;41(4):550-556. doi: 10.1097/PAS.0000000000000794.

PMID:
28009609
20.

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.

Trinh VQ, Benzerdjeb N, Chagnon-Monarque S, Dionne N, Delouya G, Kougioumoutzakis A, Sirois J, Albadine R, Latour M, Mes-Masson AM, Hovington H, Bergeron A, Zorn KC, Fradet Y, Saad F, Taussky D, Trudel D.

Radiat Oncol. 2019 Apr 25;14(1):60. doi: 10.1186/s13014-019-1267-3.

Supplemental Content

Support Center